Can You Sue for Vision Loss After Taking Ozempic or Wegovy?
Explainer from a bar association · Reference piece
Headline as published by Illinois Lawyer Now (ISBA) on Nov 20, 2026; collected by the wire Nov 20, 2026, 6:15 PM ET.
If you suffered permanent vision loss after taking Ozempic, Wegovy, or another GLP-1 medication, you may have grounds to file a pharmaceutical injury lawsuit. A new FDA warning has raised serious questions about whether drug manufacturers adequately disclosed the potential risk of a rare eye condition that can cause blindness. On November 9, 2026, the... Continue Reading
Coverage
Named in this story
- AgencyU.S. Food and Drug AdministrationMatched on
FDA
- MDLMDL 3094 · GLP-1 Receptor AgonistsMatched on
GLP-1
Topics
- Mass torts and MDLsMatched on
GLP-1
- Lawsuits and filingsMatched on
lawsuit
Explore the named firms, organizations and MDL dockets above. Sources and method
MDL No. 3094
GLP-1 Receptor Agonists
IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
- Transferee judge
- Karen S. Marston
- Court
- Eastern District of Pennsylvania
- Actions pending
- 4,025
Per the JPML pending-dockets report of October 1, 2026.